Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-011385)

Filing Details

Accession Number:: 0001415889-24-011385
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-04-23 17:23:41
Reporting Period:: 2024-04-22

Accepted Time:: 2024-04-23 17:23:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1703647	Korro Bio Inc.	KRRO	Pharmaceutical Preparations (2834)	472324450

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1885327	Atlas Venture Opportunity Fund Ii, L.p.	300 Technology Square, 8Th Floor Cambridge MA 02139		No	No	No	No
1935810	Atlas Venture Associates Opportunity Ii, Llc	300 Technology Square, 8Th Floor Cambridge MA 02139		No	No	Yes	No
1935814	Atlas Venture Associates Opportunity Ii, Lp	300 Technology Square, 8Th Floor Cambridge MA 02139		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-04-22	17,857	$56.00	195,074	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The shares are owned directly by Atlas Venture Opportunity Fund II, L.P. ("AVOF II"). Atlas Venture Associates Opportunity II, L.P. ("AVAO II LP") is the general partner of AVOF II. Atlas Venture Associates Opportunity II, LLC ("AVAO II LLC") is the general partner of AVAO II LP. Each of AVAO II LP and AVAO II LLC disclaims beneficial ownership of the securities held by AVOF II, except to the extent of its pecuniary interest therein, if any.